GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (OSTO:EQL) » Definitions » Future 3-5Y EPS without NRI Growth Rate

EQL Pharma AB (OSTO:EQL) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Jul. 21, 2025)


View and export this data going back to 2024. Start your Free Trial

What is EQL Pharma AB Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, EQL Pharma AB's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of EQL Pharma AB's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EQL Pharma AB's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

EQL Pharma AB  (OSTO:EQL) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

EQL Pharma AB Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

EQL Pharma AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (OSTO:EQL) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
OSTO:CRNO B OSTO:DICOT OSTO:CINPHA OSTO:ORX OSTO:ENZY OSTO:MOB OSTO:NANEXA XSAT:ACUC OSTO:ERMA OSTO:TOL ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
7JK:Germany
Address
Stortorget 1, 3rd Floor, Lund, SWE, 222 23
Website
http://www.eqlpharma.com
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB Headlines

From GuruFocus

ALPS Equal Sector Weight ETF Declares Fourth Quarter Distribution

By PRNewswire PRNewswire • 12-19-2019

ALPS Equal Sector Weight ETF Declares First Quarter Distribution

By PRNewswire PRNewswire • 03-19-2020

ALPS Equal Sector Weight ETF Declares Second Quarter Distribution

By PRNewswire PRNewswire • 06-18-2020

ALPS Equal Sector Weight ETF Declares Third Quarter Distribution

By PRNewswire PRNewswire • 09-19-2019